Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early‐stage hepatocellular carcinoma: An analysis of SEER‐medicare

Introduction For early‐stage hepatocellular carcinoma (HCC) patients, ablative strategies are potentially curative treatment options. Stereotactic body radiotherapy (SBRT) has emerged as a promising ablative therapy, although its comparison with radiofrequency ablation (RFA) remains confined to a si...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical imaging and radiation oncology 2018-10, Vol.62 (5), p.673-681
Hauptverfasser:	Parikh, Neehar D, Marshall, Vincent D, Green, Michael, Lawrence, Theodore S, Razumilava, Nataliya, Owen, Dawn, Singal, Amit G, Feng, Mary
Format:	Artikel
Sprache:	eng
Schlagworte:	Ablation Aged Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - surgery comparative Cost analysis Cost-Benefit Analysis Costs Epidemiology Female Hazard assessment HCC Hospital Costs - statistics & numerical data Humans ICER Length of Stay - statistics & numerical data Liver cancer Liver cirrhosis Liver Neoplasms - pathology Liver Neoplasms - surgery Male Medicare Multivariate analysis Neoplasm Staging Patients Propensity Score Radiation therapy Radio frequency Radiofrequency Ablation - methods Radiosurgery - methods RFA SBRT SEER Program Survival Survival analysis Survival Rate Treatment Outcome United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!